If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMADE.L Regulatory News (MADE)

  • There is currently no data for MADE

Form 8.5 (EPT/RI) - Made.com Group plc

3 Oct 2022 10:26

RNS Number : 5482B
JPMorgan Securities Plc
03 October 2022
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

J.P. Morgan Securities Plc

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Made.com Group plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Corporate Broker to Made.com Group plc

(d) Date dealing undertaken:

30 September 2022

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

0.01p ordinary

Purchase

 

Sale

61,319

 

154,144

0.0356 GBP

 

0.0358 GBP

0.0325 GBP

 

0.0358 GBP

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

 

 

 

Date of disclosure:

3 October 2022

Contact name:

Alwyn Basch

Telephone number:

020 7742 7407

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. 

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERFIFFAIELVIIF
Date   Source Headline
21st Jun 202212:41 pmRNSBlock Listing Application
16th May 20227:01 amRNSDirectorate Change
16th May 20227:00 amRNSTrading Update
9th May 20227:00 amRNSAcquisition
5th May 20224:23 pmRNSResult of AGM
5th May 20228:30 amRNSDirectorate Change
11th Apr 202211:59 amRNSHolding(s) in Company
6th Apr 202212:43 pmRNSDirector/PDMR Shareholding
1st Apr 202212:25 pmRNSNotice of AGM
25th Mar 20227:00 amRNSDirectorate Change
17th Mar 202211:26 amRNSAnnual Financial Report
8th Mar 20227:00 amRNSPreliminary Results
28th Feb 202211:26 amRNSTotal Voting Rights
21st Feb 20227:00 amRNSDirectorate Change
31st Jan 202210:17 amRNSTotal Voting Rights
6th Jan 20227:00 amRNSTrading Statement
31st Dec 20219:38 amRNSTotal Voting Rights
21st Dec 202110:31 amRNSBlock listing Interim Review
15th Dec 20213:31 pmRNSCompletion of Capital Reduction
9th Dec 20217:00 amRNSTrading Update
30th Nov 202111:01 amRNSTotal Voting Rights
29th Oct 202110:08 amRNSTotal Voting Rights
30th Sep 202110:07 amRNSTotal Voting Rights
14th Sep 20217:00 amRNSInterim Results for the six months to 30 June 2021
31st Aug 202110:42 amRNSTotal Voting Rights
3rd Aug 20215:01 pmRNSHolding(s) in Company
30th Jul 202111:21 amRNSTotal Voting Rights
30th Jul 20217:00 amRNSNotice of Half Year Results
30th Jul 20217:00 amRNSAppointment of Joint Corporate Brokers
23rd Jul 20212:46 pmRNSHolding(s) in Company
23rd Jul 20211:47 pmRNSHolding(s) in Company
16th Jul 20217:00 amRNSStabilisation Notice
16th Jul 20217:00 amRNSExercise of Over-allotment Option
14th Jul 20217:00 amRNSStabilisation Notice
13th Jul 20214:17 pmRNSDirector/PDMR Shareholding
7th Jul 20217:00 amRNSStabilisation Notice
1st Jul 202112:10 pmRNSHolding(s) in Company
1st Jul 202112:08 pmRNSHolding(s) in Company
30th Jun 202112:10 pmRNSTotal Voting Rights
30th Jun 20217:00 amRNSStabilisation Notice
24th Jun 202110:58 amRNSHolding(s) in Company
24th Jun 202110:47 amRNSDirector/PDMR Shareholding - Correction
23rd Jun 20212:35 pmRNSHolding(s) in Company
23rd Jun 20217:00 amRNSStabilisation Notice
21st Jun 202110:21 amRNSDirector/PDMR Shareholding
21st Jun 202110:15 amRNSHolding(s) in Company
21st Jun 20218:00 amRNSAdmission to Trading
17th Jun 202111:03 amRNSBlock Listing Application
16th Jun 20211:26 pmRNSApproval and Publication of Prospectus

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.